Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using ontologies to describe mouse phenotypes.

Georgios V Gkoutos1, Eain C J Green, Ann-Marie Mallon

  • 1Bioinformatics Group, MRC Mammalian Genetics Unit, Harwell, Oxfordshire, OX11 0RD, UK. g.gkoutos@har.mrc.ac.uk

Genome Biology
|January 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Open and sustainable AI: challenges, opportunities and the road ahead in the life sciences.

Nature methods·2026
Same author

Fostering and sustaining collaborative innovation: Insights from ELIXIR Europe's life science Communities.

F1000Research·2025
Same author

An exploratory machine learning study on paediatric abdominal pain phenotyping and prediction.

PloS one·2025
Same author

Genetic architecture of hypertrophic cardiomyopathy in individuals of Chinese and United Kingdom ancestry.

Precision clinical medicine·2025
Same author

A computational framework for inferring species dynamics and interactions with applications in microbiota ecology.

NPJ systems biology and applications·2025
Same author

Publisher Correction: Extensive identification of genes involved in congenital and structural heart disorders and cardiomyopathy.

Nature cardiovascular research·2025
Same journal

UK Biobank whole-genome sequencing reveals robust contributions of rare variants to complex-trait heritability.

Genome biology·2026
Same journal

A one-week automated genome-wide optical pooled screen using OttoSeq.

Genome biology·2026
Same journal

Integrated lipidomic and transcriptomic profiling of the host response in human malaria.

Genome biology·2026
Same journal

Centromeric satellite expansion drives genome evolution in the snowy owl.

Genome biology·2026
Same journal

Mapping the landscape of allele-specific expression in porcine genomes.

Genome biology·2026
Same journal

Genomic sequence evolution underlying human neocortical interareal diversification.

Genome biology·2026
See all related articles

Developing a new compositional approach to describe mouse phenotypes aids bioinformatics data mining for human genetic disease research. This structured method enhances data analysis and understanding of complex genetic conditions.

Area of Science:

  • Bioinformatics
  • Genetics
  • Computational Biology

Background:

  • Mice are crucial models for studying human genetic diseases.
  • Standardized description of mutant mouse phenotypes is essential for effective data mining.
  • Current methods face challenges in flexibility and power for bioinformatics.

Purpose of the Study:

  • To introduce a novel, compositional approach for describing mouse phenotypes.
  • To enhance the standardization and structure of phenotype data for bioinformatics.
  • To create a more flexible and powerful framework for data mining.

Main Methods:

  • Combining core ontologies from diverse sources.
  • Developing a compositional framework for phenotype description.
  • Utilizing a structured approach for mutant mouse data.

Related Experiment Videos

Main Results:

  • The proposed framework offers greater flexibility and power compared to previous methods.
  • The compositional approach facilitates more efficient data mining.
  • A standardized method for describing complex phenotypes was developed.

Conclusions:

  • The novel compositional approach addresses key challenges in mouse phenotype description for bioinformatics.
  • This framework improves data mining capabilities for genetic disease research.
  • Further discussion on the implications and issues of this approach is provided.